These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 29480848)

  • 1. Exenatide once weekly for smoking cessation: study protocol for a randomized clinical trial.
    Yammine L; Kosten TR; Cinciripini PM; Green CE; Meininger JC; Minnix JA; Newton TF
    Medicine (Baltimore); 2018 Jan; 97(2):e9567. PubMed ID: 29480848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exenatide Adjunct to Nicotine Patch Facilitates Smoking Cessation and May Reduce Post-Cessation Weight Gain: A Pilot Randomized Controlled Trial.
    Yammine L; Green CE; Kosten TR; de Dios C; Suchting R; Lane SD; Verrico CD; Schmitz JM
    Nicotine Tob Res; 2021 Aug; 23(10):1682-1690. PubMed ID: 33831213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exenatide as an adjunct to nicotine patch for smoking cessation and prevention of postcessation weight gain among treatment-seeking smokers with pre-diabetes and/or overweight: study protocol for a randomised, placebo-controlled clinical trial.
    Yammine L; Verrico CD; Versace F; Webber HE; Suchting R; Weaver MF; Kosten TR; Alibhai H; Cinciripini PM; Lane SD; Schmitz JM
    BMJ Open; 2023 Jun; 13(6):e072707. PubMed ID: 37316311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Smokers deprived of cigarettes for 72 h: effect of nicotine patches on craving and withdrawal.
    Teneggi V; Tiffany ST; Squassante L; Milleri S; Ziviani L; Bye A
    Psychopharmacology (Berl); 2002 Nov; 164(2):177-87. PubMed ID: 12404080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucagon-like peptide-1 analogues: a new way to quit smoking? (SKIP)-a structured summary of a study protocol for a randomized controlled study.
    Lengsfeld S; Burkard T; Meienberg A; Jeanloz N; Coynel D; Vogt DR; Hemkens LG; Speich B; Zanchi D; Erlanger TE; Christ-Crain M; Winzeler B
    Trials; 2023 Apr; 24(1):284. PubMed ID: 37081574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of nicotine lozenges on affective smoking withdrawal symptoms: secondary analysis of a randomized, double-blind, placebo-controlled clinical trial.
    Shiffman S
    Clin Ther; 2008 Aug; 30(8):1461-75. PubMed ID: 18803988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical efficacy and safety of once-weekly glucagon-like peptide-1 agonists in development for treatment of type 2 diabetes mellitus in adults.
    Tzefos M; Harris K; Brackett A
    Ann Pharmacother; 2012 Jan; 46(1):68-78. PubMed ID: 22232377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What a difference a day makes: differences in initial abstinence response during a smoking cessation attempt.
    Piper ME; Vasilenko SA; Cook JW; Lanza ST
    Addiction; 2017 Feb; 112(2):330-339. PubMed ID: 27633341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of nicotine lozenge use prior to smoking cue presentation on craving and withdrawal symptom severity.
    Kotlyar M; Vogel RI; Dufresne SR; Mills AM; Vuchetich JP
    Drug Alcohol Depend; 2020 Jan; 206():107706. PubMed ID: 31757519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Nicotine Patch vs Varenicline vs Combination Nicotine Replacement Therapy on Smoking Cessation at 26 Weeks: A Randomized Clinical Trial.
    Baker TB; Piper ME; Stein JH; Smith SS; Bolt DM; Fraser DL; Fiore MC
    JAMA; 2016 Jan; 315(4):371-9. PubMed ID: 26813210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Varenicline versus transdermal nicotine patch for smoking cessation: results from a randomised open-label trial.
    Aubin HJ; Bobak A; Britton JR; Oncken C; Billing CB; Gong J; Williams KE; Reeves KR
    Thorax; 2008 Aug; 63(8):717-24. PubMed ID: 18263663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exenatide once weekly plus dapagliflozin once daily versus exenatide or dapagliflozin alone in patients with type 2 diabetes inadequately controlled with metformin monotherapy (DURATION-8): a 28 week, multicentre, double-blind, phase 3, randomised controlled trial.
    Frías JP; Guja C; Hardy E; Ahmed A; Dong F; Öhman P; Jabbour SA
    Lancet Diabetes Endocrinol; 2016 Dec; 4(12):1004-1016. PubMed ID: 27651331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of topiramate on cue-induced cigarette craving and the response to a smoked cigarette in briefly abstinent smokers.
    Reid MS; Palamar J; Raghavan S; Flammino F
    Psychopharmacology (Berl); 2007 May; 192(1):147-58. PubMed ID: 17345064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of Non-Nicotinic E-Cigarettes to Reduce Cue- and Abstinence-Induced Cigarette Craving in Non-Treatment Seeking Daily Dependent Smokers.
    Ng G; Attwells S; Selby P; Zawertailo L
    Psychopharmacology (Berl); 2021 Jun; 238(6):1461-1472. PubMed ID: 33515267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Pilot Study of E-Cigarette Naïve Cigarette Smokers and the Effects on Craving After Acute Exposure to E-Cigarettes in the Laboratory.
    De La Garza R; Shuman SL; Yammine L; Yoon JH; Salas R; Holst M
    Am J Addict; 2019 Sep; 28(5):361-366. PubMed ID: 31066987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of varenicline versus transdermal nicotine replacement therapy on cigarette demand on quit day in individuals with substance use disorders.
    Murphy CM; MacKillop J; Martin RA; Tidey JW; Colby SM; Rohsenow DJ
    Psychopharmacology (Berl); 2017 Aug; 234(16):2443-2452. PubMed ID: 28500373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Smoking reduction and temporary abstinence: new approaches for smoking cessation].
    Le Houezec J; Säwe U
    J Mal Vasc; 2003 Dec; 28(5):293-300. PubMed ID: 14978435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cigarette craving and withdrawal symptoms during temporary abstinence and the effect of nicotine gum.
    Brown J; Hajek P; McRobbie H; Locker J; Gillison F; McEwen A; Beard E; West R
    Psychopharmacology (Berl); 2013 Sep; 229(1):209-18. PubMed ID: 23636302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Varying nicotine patch dose and type of smoking cessation counseling.
    Jorenby DE; Smith SS; Fiore MC; Hurt RD; Offord KP; Croghan IT; Hays JT; Lewis SF; Baker TB
    JAMA; 1995 Nov; 274(17):1347-52. PubMed ID: 7563558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A placebo-controlled randomized trial of D-cycloserine augmentation of cue exposure therapy for smoking cessation.
    Otto MW; Pachas GN; Cather C; Hoeppner SS; Moshier SJ; Hearon BA; Ward HB; Laffer AB; Smits JAJ; Evins AE
    Cogn Behav Ther; 2019 Jan; 48(1):65-76. PubMed ID: 30111253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.